Literature DB >> 27644223

Mitral valve repair facilitated with transapical beating heart NeoChord implantation in a non-Hodgkin's lymphoma patient.

Ali Sait Kavakli1, Raif Umut Ayoglu2, Nilgun Kavrut Ozturk3, Omer Haldun Tekinalp2, Zehra Erkal4, Kerem Inanoglu3, Mustafa Emmiler2.   

Abstract

Elderly patients with severe hematological malignancies may require cardiac surgery. The combined impact of cardiopulmonary bypass (CPB) and surgical trauma is a potent inflammatory activator and is increased by intraoperative and postoperative complications. To avoid the adverse effects of CPB, minimally invasive off-pump techniques may be used in these patients. The transapical off-pump mitral valve intervention with NeoChord implantation (TOP-MINI) is a minimally invasive technique for mitral valve repair, which makes it possible to avoid the risks of CPB in selected patients, such as elderly, cancer or immunosuppressive patients. We report here the case of a 78-year-old male with B-cell non-Hodgkin's lymphoma, who presented with severe mitral regurgitation. The patient was successfully treated with the TOP-MINI procedure.

Entities:  

Keywords:  Cardiac surgery; Minimal invasive; Mitral regurgitation; Non-Hodgkin’s lymphoma; Transapical mitral valve repair

Mesh:

Year:  2016        PMID: 27644223     DOI: 10.1007/s00540-016-2251-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

Review 1.  Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide.

Authors:  Andrea Colli; Fabio Zucchetta; Gianluca Torregrossa; Erica Manzan; Eleonora Bizzotto; Laura Besola; Roberto Bellu; Cristiano Sarais; Demetrio Pittarello; Gino Gerosa
Journal:  Ann Cardiothorac Surg       Date:  2015-05

2.  Coronary artery bypass surgery in patients with malignancy: a single-center study with comparison to patients without malignancy.

Authors:  Nezihi Kucukarslan; Tolga Tatar; Mehmet Uzun; Izzet Yavuz; Ertugrul Ozal; Harun Tatar
Journal:  J Card Surg       Date:  2009 Mar-Apr       Impact factor: 1.620

3.  Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality.

Authors:  Justin Chan; Franklin Rosenfeldt; Krishanu Chaudhuri; Silvana Marasco
Journal:  Heart Lung Circ       Date:  2012-03-02       Impact factor: 2.975

4.  Impact of malignant hematological disorders on cardiac surgery.

Authors:  S Christiansen; C Schmid; A Löher; H H Scheld
Journal:  Cardiovasc Surg       Date:  2000-03

5.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

Authors:  J P Singh; J C Evans; D Levy; M G Larson; L A Freed; D L Fuller; B Lehman; E J Benjamin
Journal:  Am J Cardiol       Date:  1999-03-15       Impact factor: 2.778

6.  Management of patients with hematological malignancies undergoing coronary artery bypass grafting.

Authors:  Deepak Borde; Uday Gandhe; Neha Hargave; Kaushal Pandey
Journal:  Ann Card Anaesth       Date:  2013 Jan-Mar

7.  Anesthetic Management of Transapical Off-Pump Mitral Valve Repair With NeoChord Implantation.

Authors:  Ali Sait Kavakli; Nilgun Kavrut Ozturk; Raif Umut Ayoglu; Mustafa Emmiler; Lutfi Ozyurek; Kerem Inanoglu; Sadik Ozmen
Journal:  J Cardiothorac Vasc Anesth       Date:  2016-06-28       Impact factor: 2.628

8.  Off-pump coronary artery bypass surgery in very high-risk patients: adjustment and preliminary results.

Authors:  Laurent Barandon; Philippe Richebé; Emmanuel Munos; Joachim Calderon; Marianne Lafitte; Stéphane Lafitte; Thierry Couffinhal; Xavier Roques
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-07-18

9.  Cardiac operations in patients with hematologic malignancies.

Authors:  Alison M Fecher; Thomas J Birdas; David Haybron; Pavlos K Papasavas; Debbie Evers; Philip F Caushaj
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

10.  Can cardiac surgery be performed safely on patients with haematological malignancies.

Authors:  A Guler; M A Sahin; F Cingoz; E Ozal; U Demirkilic; M Arslan
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.